High throughput screening News and Research

RSS
High-throughput screening (HTS) allows scientists to test thousands of samples at once. These samples can be of a wide variety, and include, but are not limited to, amino acids, chemical compounds or cells.
First patient-derived stem cell model developed for studying oculocutaneous albinism

First patient-derived stem cell model developed for studying oculocutaneous albinism

An integrated computational methodology for COVID drug prioritization

An integrated computational methodology for COVID drug prioritization

Homologous mRNA and heterologous vaccines elicit high immune responses

Homologous mRNA and heterologous vaccines elicit high immune responses

Monitoring cellular metabolism for NAFLD/NASH liver disease research

Monitoring cellular metabolism for NAFLD/NASH liver disease research

Discovery of new receptor that interacts with SARS-CoV-2 spike, suppresses infection

Discovery of new receptor that interacts with SARS-CoV-2 spike, suppresses infection

Cell-based viral replication system for screening of SARS-CoV-2 drugs

Cell-based viral replication system for screening of SARS-CoV-2 drugs

Invalidation of potential SARS-CoV-2 protease inhibitors

Invalidation of potential SARS-CoV-2 protease inhibitors

Scientists develop a high-throughput, cell-free screening platform for anti-SARS-CoV-2 antibody discovery

Scientists develop a high-throughput, cell-free screening platform for anti-SARS-CoV-2 antibody discovery

ioSkeletal Myocytes | New product launch

ioSkeletal Myocytes | New product launch

Machine learning algorithms accelerate the protein engineering process

Machine learning algorithms accelerate the protein engineering process

Small molecule drug can attenuate the triggers of neuroinflammation, preclinical study shows

Small molecule drug can attenuate the triggers of neuroinflammation, preclinical study shows

UTSA receives $3.2 million CPRIT grant for developing new approach to fight against cancer

UTSA receives $3.2 million CPRIT grant for developing new approach to fight against cancer

First-in-kind kidney cancer drug developed at UTSW receives FDA approval

First-in-kind kidney cancer drug developed at UTSW receives FDA approval

Scientists identify calpeptin as potential inhibitor of SARS-CoV-2

Scientists identify calpeptin as potential inhibitor of SARS-CoV-2

A path to treat currently untreatable cases of cystic fibrosis is clearly achievable, study suggests

A path to treat currently untreatable cases of cystic fibrosis is clearly achievable, study suggests

New screening method tests the effectiveness of drug compounds that 'glue' proteins together

New screening method tests the effectiveness of drug compounds that 'glue' proteins together

New article focuses on drug discovery targeting SARS-CoV-2

New article focuses on drug discovery targeting SARS-CoV-2

Optibrium Publishes Major Peer-Reviewed Study on AI Applications to Global Pharma Data

Optibrium Publishes Major Peer-Reviewed Study on AI Applications to Global Pharma Data

Study reviews natural drug candidates for potential treatment of COVID-19

Study reviews natural drug candidates for potential treatment of COVID-19

Waters launches new RUO LC-MS test method to advance infectious disease research

Waters launches new RUO LC-MS test method to advance infectious disease research